These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20386345)

  • 1. Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.
    Naves-Díaz M; Carrillo-López N; Rodríguez-Rodríguez A; Braga S; Fernández-Coto T; Lopez-Novoa JM; López-Hernández F; Cannata-Andía JB
    Menopause; 2010 Jul; 17(4):766-71. PubMed ID: 20386345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
    El-Shitany NA; Hegazy S; El-Desoky K
    Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomechanical and histological outcome of combined raloxifene-estrogen therapy on skeletal and reproductive tissues.
    Tasci A; Bilgili H; Altunay H; Gecit MR; Keskin D
    Eur J Pharmacol; 2010 Feb; 627(1-3):354-61. PubMed ID: 19903467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estradiol, calcitriol and both treatments combined on bone histomorphometry in rats with chronic kidney disease and ovariectomy.
    Naves Díaz M; Rodríguez Rodríguez A; Fernández Martín JL; Serrano Arias M; Menéndez Rodríguez P; Cannata Andía JB
    Bone; 2007 Oct; 41(4):614-9. PubMed ID: 17692587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17beta and to raloxifene in rat organs.
    Somjen D; Shen M; Stern N; Mirsky N
    J Cell Biochem; 2006 Sep; 99(1):133-9. PubMed ID: 16598752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effect of soy protein, soy isoflavones, and 17beta-estradiol on bone metabolism in adult ovariectomized rats.
    Cai DJ; Zhao Y; Glasier J; Cullen D; Barnes S; Turner CH; Wastney M; Weaver CM
    J Bone Miner Res; 2005 May; 20(5):828-39. PubMed ID: 15824856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
    Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
    J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
    Black LJ; Sato M; Rowley ER; Magee DE; Bekele A; Williams DC; Cullinan GJ; Bendele R; Kauffman RF; Bensch WR
    J Clin Invest; 1994 Jan; 93(1):63-9. PubMed ID: 8282823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats.
    Westerlind KC; Gibson KJ; Malone P; Evans GL; Turner RT
    J Bone Miner Res; 1998 Jun; 13(6):1023-31. PubMed ID: 9626634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men.
    Doran PM; Riggs BL; Atkinson EJ; Khosla S
    J Bone Miner Res; 2001 Nov; 16(11):2118-25. PubMed ID: 11697809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene plus 17beta-estradiol inhibits proliferation of primary cultured vascular smooth muscle cells and human mammary endothelial cells via the janus kinase/signal transducer and activator of transcription3 cascade.
    Wang TH; Xiang QL; Chen JW; Pan H; Cui YH
    Eur J Pharmacol; 2007 Apr; 561(1-3):7-13. PubMed ID: 17336289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
    Le Saux M; Di Paolo T
    J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intranasal 17beta-estradiol and raloxifene on lipid profile and fibrinogen in hypercholesterolemic postmenopausal women: a randomized, placebo-controlled clinical trial.
    Engin-Ustün Y; Ustün Y; Meydanli MM; Kafkasli A
    Gynecol Endocrinol; 2006 Dec; 22(12):676-9. PubMed ID: 17162709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.